What is a monoclonal antibody and how does it affect pets?
04/10/2025
Index
Introduction
Many pet owners wonder what monoclonal antibodies are and how this innovation can be applied in veterinary medicine. This type of therapy, which has already revolutionized treatments in humans, is also gaining ground in animal health, especially in dogs.
With pets living longer, diseases such as cancer, allergies, and autoimmune disorders have become more common. In this context, monoclonal antibodies represent a modern, safe, and effective alternative.
However, to make its use even more effective, genetic testing for dogs comes into play, allowing treatments to be personalized according to each animal's DNA.
What is a monoclonal antibody and why is it relevant?

So, what is a monoclonal antibody? A monoclonal antibody can be defined as a protein produced in a laboratory to bind specifically to a target in the body. To illustrate, imagine a key custom-made to open only one lock.
In dogs, these antibodies can be used for:
Attack tumor cells.
Neutralize molecules that cause inflammation.
Blocking receptors linked to allergies.
Regulate exaggerated immune responses.
This selectivity is the great advantage of monoclonal antibodies. Furthermore, it is what differentiates them from traditional medications, which can act broadly and cause side effects.
What is a monoclonal antibody: applications in dogs
Today, there are already monoclonal antibodies approved for veterinary use, especially in dogs. The best-known examples are those indicated for:
Canine atopic dermatitis , an allergic condition that causes intense itching and discomfort.
Lymphoma, a type of cancer that affects the lymphatic system.
Osteoarthritis, a common disease in old age, causing joint pain in pets.
These therapies offer rapid symptom relief and significantly improve the animals' quality of life.
The role of animal genetics

Each dog has a unique DNA, which influences everything from physical characteristics to how its body reacts to medication.
Genetic testing in dogs can identify:
Predisposition to diseases : Specific mutations can increase the risk of cancer or immunological disorders, indicating the need for earlier therapies.
Response to medications: Genetic variations influence how the body metabolizes or reacts to certain drugs, including monoclonal antibodies.
Risk of adverse effects: Genetic testing helps predict incompatibilities and prevent unwanted reactions.
Personalized veterinary medicine
The integration of monoclonal antibodies and genetic testing marks the beginning of personalized medicine in dogs. This means that treatment is no longer standardized but is adapted to the genetic profile of each animal.
In practice, this makes it possible to:
More precise selection of the appropriate monoclonal antibody.
Adjust the dosage according to the dog's metabolism.
More effective monitoring of treatment response.
Reducing therapeutic trial and error.
Benefits for dogs and their owners.

By combining knowledge about what monoclonal antibodies are with advances in genetics, the benefits extend to both dogs and their owners.
Among the main results are:
Greater effectiveness in controlling serious and chronic diseases.
Fewer side effects, since the treatments are targeted.
Early diagnosis of genetic predispositions.
Increased life expectancy, thanks to safer therapies.
Improved quality of life, with a reduction in symptoms and discomfort.
For pet owners, this means greater safety and confidence in the chosen treatment, as well as the peace of mind of offering their pet a modern option adapted to their individual needs.
Meet petgenoma: your partner in genetic testing for pets.
If you are looking for a reliable and innovative solution to provide a better quality of life for your pet, genetic testing is essential, and petgenoma is the ideal company for this.

Specializing in pet genetics, petgenoma offers highly accurate tests, focusing on preventative medicine, breed identification, and disease predisposition. With our own laboratory and national database, we guarantee results with 98% accuracy using Illumina technology.
The process is simple: the pet owner collects the sample at home using a buccal swab, sends it to the lab, and receives the results within 15 business days, with full support throughout all stages.
The company offers different kits, geared towards dogs and cats. With the Breed Identification Kit , you have access to the pet's origin, confirmation of parentage, consanguinity, and physical characteristics.
Want more? Then you might be interested in the Premium Kit , which offers breed evaluation and also analyzes more than 300 diseases. There's also the Premium Clinical Kit , which provides all of that, plus analyzes your pet's oncological and obesity risks.
Therefore, if you want to get to know your pet deeply and ensure a healthier life for them, count on petgenoma. Learn about our products and discover how genetics can transform your relationship with your furry friend!
What is a monoclonal antibody: conclusion
Understanding what monoclonal antibodies are is essential for anyone who wants to keep up with advances in veterinary medicine. These antibodies represent a revolution in the treatment of diseases in dogs, offering more effective and safer solutions compared to conventional therapies.
Thus, pet owners and veterinarians now have powerful tools at their disposal to ensure not only more years of life for dogs, but also greater well-being at every stage. The integration of monoclonal antibodies and animal genetics is undoubtedly one of the most promising paths in modern veterinary medicine.
Essay
Petgenoma